Neurological Emergencies Treatment Trials - Antihypertensive Treatment of Acute Cerebral Hemorrhage-II (NETT # ATACH II): A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage

Grants and Contracts Details

Description

Intensive SBP reduction using IV nicardipine with treatment initiated within 3 hours of ICH onset and continued for the next 24 hours reduces the likelihood of death or disability at Day 90 (defined by mRS of 4-6) by absolute 10% (or relative 17%) or greater compared with standard SBP reduction using IV nicardipine.
StatusFinished
Effective start/end date10/1/137/31/16

Funding

  • University of Michigan: $15,888.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.